ai:leen

This company utilizes Generative AI technology to accelerate the adoption of new cancer therapies. Their platform analyzes medical images to predict disease progression and treatment response, informing oncologists for faster patient matching. The core value is enabling earlier access to life-saving treatments, improving patient outcomes significantly.

Traction –/10

Salzburg, Austria · HQ

250+ followers

Artificial Intelligence
Data & Analytics
Digital Health
Healthcare Technology
Software Only

Updated 5 months ago

Funding

Funding rounds are not available yet.

Founders

1 founder

Anna Tidstam

Founder Disease Simulation AI

Product

Features

This company utilizes Generative AI technology to accelerate the adoption of new cancer therapies. Their platform analyzes medical images to predict disease progression and treatment response, informing oncologists for faster patient matching. The core value is enabling earlier access to life-saving treatments, improving patient outcomes significantly.